BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 31915915)

  • 1. 25-Hydroxy vitamin D deficiency predicts inferior prognosis in mantle cell lymphoma.
    Xu DM; Liang JH; Wang L; Zhu HY; Xia Y; Fan L; Li JY; Xu W
    J Cancer Res Clin Oncol; 2020 Apr; 146(4):1003-1009. PubMed ID: 31915915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 25-Hydroxy vitamin D deficiency predicts inferior prognosis in Hodgkin lymphoma.
    Qin JQ; Yin H; Wu JZ; Chen RZ; Xia Y; Wang L; Zhu HY; Fan L; Li JY; Liang JH; Xu W
    Leuk Res; 2021 Jun; 105():106580. PubMed ID: 33836479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic value of 25-hydroxy vitamin D deficiency and its interaction with c-Myc expression in diffuse large B cell lymphoma.
    Wang WT; Liang JH; Wang L; Zhu HY; Xia Y; Fan L; Li JY; Xu W
    Ann Hematol; 2020 Oct; 99(10):2377-2384. PubMed ID: 32728938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of 25-hydroxy vitamin D in extranodal NK/T cell lymphoma.
    Mao J; Yin H; Wang L; Wu JZ; Xia Y; Zhu HY; Fan L; Li JY; Liang JH; Xu W
    Ann Hematol; 2021 Feb; 100(2):445-453. PubMed ID: 33140135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 25-Hydroxy vitamin D deficiency is an inferior predictor of peripheral T-cell lymphomas.
    Shen HR; Tang J; Li WY; Liang JH; Li Y; Wu JZ; Wang L; Li JY; Gao R; Yin H; Xu W
    Ann Hematol; 2024 Feb; 103(2):565-574. PubMed ID: 37951853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum beta-2 microglobulin as a prognostic biomarker in patients with mantle cell lymphoma.
    Yoo C; Yoon DH; Kim S; Huh J; Park CS; Park CJ; Lee SW; Suh C
    Hematol Oncol; 2016 Mar; 34(1):22-7. PubMed ID: 25689467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simplified MIPI-B prognostic stratification method can predict the outcome well-retrospective analysis of clinical characteristics and management of newly-diagnosed mantle cell lymphoma patients from China.
    He JS; Chen X; Wei GQ; Sun J; Zheng WY; Shi JM; Wu WJ; Zhao Y; Zheng GF; Huang H; Cai Z
    Medicine (Baltimore); 2019 Jan; 98(1):e13741. PubMed ID: 30608386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complex karyotype in patients with mantle cell lymphoma predicts inferior survival and poor response to intensive induction therapy.
    Greenwell IB; Staton AD; Lee MJ; Switchenko JM; Saxe DF; Maly JJ; Blum KA; Grover NS; Mathews SP; Gordon MJ; Danilov AV; Epperla N; Fenske TS; Hamadani M; Park SI; Flowers CR; Cohen JB
    Cancer; 2018 Jun; 124(11):2306-2315. PubMed ID: 29579328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin D insufficiency and prognosis in non-Hodgkin's lymphoma.
    Drake MT; Maurer MJ; Link BK; Habermann TM; Ansell SM; Micallef IN; Kelly JL; Macon WR; Nowakowski GS; Inwards DJ; Johnston PB; Singh RJ; Allmer C; Slager SL; Weiner GJ; Witzig TE; Cerhan JR
    J Clin Oncol; 2010 Sep; 28(27):4191-8. PubMed ID: 20713849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can the prognosis of mantle cell lymphoma be predicted by simple CBC counts?
    Haydaroglu Sahin H
    Medicine (Baltimore); 2019 Jul; 98(30):e16180. PubMed ID: 31348229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD5-negative Mantle Cell Lymphoma: Clinicopathologic Correlations and Outcome in 58 Patients.
    Miao Y; Lin P; Saksena A; Xu J; Wang M; Romaguera J; Yin CC; Medeiros LJ; Li S
    Am J Surg Pathol; 2019 Aug; 43(8):1052-1060. PubMed ID: 31045891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-analysis of the prognostic and clinical value of serum 25-hydroxyvitamin D levels in previously untreated lymphoma.
    Tao Y; Chen H; Zhou Y; Shi Y
    Future Oncol; 2021 May; 17(14):1825-1838. PubMed ID: 33728948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin D deficiency is associated with a poor prognosis in advanced non-small cell lung cancer patients treated with platinum-based first-line chemotherapy.
    Ma K; Xu W; Wang C; Li B; Su K; Li W
    Cancer Biomark; 2017; 18(3):297-303. PubMed ID: 27983538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic model for mantle cell lymphoma in the rituximab era: a nationwide study in Japan.
    Chihara D; Asano N; Ohmachi K; Kinoshita T; Okamoto M; Maeda Y; Mizuno I; Matsue K; Uchida T; Nagai H; Nishikori M; Nakamura S; Ogura M; Suzuki R
    Br J Haematol; 2015 Sep; 170(5):657-68. PubMed ID: 25953436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absolute monocyte count predicts overall survival in mantle cell lymphomas: correlation with tumour-associated macrophages.
    Koh YW; Shin SJ; Park C; Yoon DH; Suh C; Huh J
    Hematol Oncol; 2014 Dec; 32(4):178-86. PubMed ID: 24910369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Value of Ki-67 Index, Cytology, and Growth Pattern in Mantle-Cell Lymphoma: Results From Randomized Trials of the European Mantle Cell Lymphoma Network.
    Hoster E; Rosenwald A; Berger F; Bernd HW; Hartmann S; Loddenkemper C; Barth TF; Brousse N; Pileri S; Rymkiewicz G; Kodet R; Stilgenbauer S; Forstpointner R; Thieblemont C; Hallek M; Coiffier B; Vehling-Kaiser U; Bouabdallah R; Kanz L; Pfreundschuh M; Schmidt C; Ribrag V; Hiddemann W; Unterhalt M; Kluin-Nelemans JC; Hermine O; Dreyling MH; Klapper W
    J Clin Oncol; 2016 Apr; 34(12):1386-94. PubMed ID: 26926679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of patients with blastoid and pleomorphic variant mantle cell lymphoma.
    Gerson JN; Handorf E; Villa D; Gerrie AS; Chapani P; Li S; Medeiros LJ; Wang M; Cohen JB; Churnetski M; Hill BT; Sawalha Y; Hernandez-Ilizaliturri FJ; Kothari S; Vose JM; Bast M; Fenske T; Rao Gari SN; Maddocks KJ; Bond D; Bachanova V; Kolla B; Chavez J; Shah B; Lansigan F; Burns T; Donovan AM; Wagner-Johnston N; Messmer M; Mehta A; Anderson JK; Reddy N; Kovach AE; Landsburg DJ; Glenn M; Inwards DJ; Ristow K; Karmali R; Kaplan JB; Caimi PF; Rajguru S; Evens A; Klein A; Umyarova E; Pulluri B; Amengual JE; Lue JK; Diefenbach C; Fisher RI; Barta SK
    Blood Adv; 2023 Dec; 7(24):7393-7401. PubMed ID: 37874912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Confirmation of the mantle-cell lymphoma International Prognostic Index in randomized trials of the European Mantle-Cell Lymphoma Network.
    Hoster E; Klapper W; Hermine O; Kluin-Nelemans HC; Walewski J; van Hoof A; Trneny M; Geisler CH; Di Raimondo F; Szymczyk M; Stilgenbauer S; Thieblemont C; Hallek M; Forstpointner R; Pott C; Ribrag V; Doorduijn J; Hiddemann W; Dreyling MH; Unterhalt M
    J Clin Oncol; 2014 May; 32(13):1338-46. PubMed ID: 24687837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D insufficiency and prognosis in chronic lymphocytic leukemia.
    Shanafelt TD; Drake MT; Maurer MJ; Allmer C; Rabe KG; Slager SL; Weiner GJ; Call TG; Link BK; Zent CS; Kay NE; Hanson CA; Witzig TE; Cerhan JR
    Blood; 2011 Feb; 117(5):1492-8. PubMed ID: 21048153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficacy and Prognosis of Chemotherapy Regimen Containing BTK Inhibitor in Treatment of Recurrent/Refractory Mantle Cell Lymphoma].
    Chen H; Liu XY; Chang Y; Chen ZQ; Li WQ; Zhang L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Feb; 32(1):125-131. PubMed ID: 38387910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.